Panacea Acquisition Corp. II

Panacea Acquisition Corp. II (Nasdaq: PANA) was a healthcare-focused blank-check company sponsored by Panacea Acquisition Holdings II LLC and backed by management with a life-sciences investment background. The vehicle went public in 2021 with a mandate to pursue targets in the healthcare and biotechnology sectors. In April 2023, the company filed a Form 15-12G with the SEC, terminating its registration under Section 12(g) of the Securities Exchange Act — a step that typically follows a SPAC's liquidation after failing to close a business combination within its allotted window. The filing, assigned accession number 0001213900-23-033685, marked the formal conclusion of the vehicle's public lifecycle. Sign up for SpacDesk to access full filing histories, timeline analytics, and sponsor-level data on PANA and hundreds of other SPAC vehicles.